Komori
Nagase & (8012) · FactFirst stated

FY2018-Q2 cumulative R&D expenses

First written in FY2018-Q2. . Latest entry: FY2018-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Ongoing disclosure of research and development expensesA theme 10 companies write about · 1 as a headwind · 4 as a tailwind

1 other company's latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2018-Q2First statedAnnual report

    「Total R&D expenses for the six months ended 30 September 2017 were ¥2.77 billion.」

    Total R&D expenses for the first-half cumulative period were stated as ¥2.77 billion. The segment table totals ¥2,778 million. In addition, R&D activities related to siloxane materials were newly added following the inclusion of INKRON LIMITED in the consolidated accounts.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nagase & yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.